Most shoulder injuries have a story. A fall, an awkward reach, a night of bad sleep that turned into a week of bad sleep. But the shoulder pain that takes hold in a woman’s mid-forties often has no story at all. No incident. No obvious cause. Just a gradual, progressive stiffening that eventually makes it impossible to reach behind her back, lift her arm overhead, or get a coat on without wincing.
Doctors have a name for it: adhesive capsulitis, better known as frozen shoulder. While it’s been a recognized condition for nearly a century, its disproportionate occurrence in women during the perimenopausal years is only now attracting the serious scientific attention it deserves. Plenty of women going through perimenopause have been told their shoulder pain is probably a rotator cuff issue, or stress, or posture. Some have spent months in physical therapy working on the wrong problem. The hormonal connection to perimenopause frozen shoulder has been hiding in plain sight, and it turns out estrogen has a lot more to do with your shoulder joint than anyone previously understood.
What Frozen Shoulder Actually Is
Frozen shoulder is an inflammatory condition in which fibrous tissue develops around the shoulder joint, causing pain, stiffness, and reduced mobility. The shoulder is encased in a capsule of connective tissue, and in frozen shoulder, that capsule thickens, tightens, and eventually develops bands of scar tissue called adhesions. As this happens, lubricating synovial fluid in the joint decreases, and the joint loses its range of motion from every direction, not just one.
A rotator cuff injury typically limits certain movements more than others. Frozen shoulder, once it takes hold, restricts the joint across all planes. Reaching overhead, rotating the arm outward, putting on a coat, reaching across the car to the passenger seat, all of it becomes limited, then painful, then sometimes impossible.
Frozen shoulder affects up to 5% of the population, with most cases occurring in peri- and postmenopausal women. It is most common in women between 40 and 60 years old. The condition moves through three distinct stages. The initial freezing phase is marked by diffuse, disabling shoulder pain that worsens at night, typically lasting from 2 to 9 months. The intermediate frozen phase brings reduced pain but persistent stiffness as the primary concern, with capsular rigidity progressively restricting the shoulder’s range of motion across all planes. This phase generally lasts between 4 to 12 months. The thawing phase brings gradual pain reduction and mobility restoration. That final stage can take anywhere from six months to two years to complete.
The whole arc, from first twinge to full recovery, can take up to 3 years in some women. Most are told to manage and wait. Many don’t realize there may be a hormonal explanation for why it happened in the first place.
The Perimenopause Frozen Shoulder Connection
In perimenopause, estrogen levels fluctuate unpredictably, causing common symptoms such as hot flashes and irregular periods. In menopause, estrogen levels drop significantly and remain permanently low. Estrogen plays an important role in nearly all parts of the body, including bones, tendons, muscles, cartilage, and ligaments.
Estrogen supports collagen structure, keeps tissues flexible, and helps regulate inflammation. As estrogen levels naturally decline during menopause, connective tissues may become less flexible and more susceptible to inflammation and fibrosis, a process where tissues overgrow, harden, and scar. That is precisely what happens inside the shoulder capsule when frozen shoulder develops.
Declining estrogen levels may play a key role in frozen shoulder development. Estrogen has natural anti-inflammatory and anti-fibrotic effects, regulating collagen production and preventing excessive tissue thickening in joint capsules. Estrogen isn’t just a reproductive hormone. It functions as a protector of joint and connective tissue integrity, and when it drops, the shoulder capsule is one of the places that shows the damage.
One recent study found that estrogen seems to help prevent thickening and scarring of tissue in people with frozen shoulder, doing this by binding to G protein-coupled estrogen receptors (GPER), specialized cellular receptors in joint tissue that respond to estrogen signaling. In practical terms, the shoulder capsule has its own estrogen receptors, and when estrogen drops during perimenopause, those receptors go dormant and the capsule becomes more vulnerable to the inflammatory and fibrotic cascade that leads to freezing.
For some women, these hormonal shifts create the perfect environment for frozen shoulder to develop. Women with additional risk factors such as diabetes, thyroid disorders, a history of shoulder injury, or cardiovascular disease may be even more susceptible. The overlap is striking: women in perimenopause are already at increased risk for thyroid dysfunction and blood sugar changes, both of which independently raise frozen shoulder risk. Add declining estrogen to that picture and you have a combination that’s particularly unkind to shoulder joint tissue.
What the Research at Duke Found
The most discussed research on the perimenopause frozen shoulder link comes out of Duke researchers. OB-GYN Anne Ford and orthopedic surgeon Jocelyn Wittstein noticed something unusual in their clinical practice: a subset of their female patients, all in or past menopause, kept showing up with frozen shoulder with no injury to explain it. Ford and Wittstein then conducted a retrospective study of 1,952 female patients between 45 and 60 years of age, analyzing their medical records for signs of menopause, hormone therapy use, and frozen shoulder diagnoses, comparing shoulder outcomes in women who received hormone replacement therapy against those who did not.
Their findings showed that less than 4 percent of those who had received hormone replacement therapy were diagnosed with frozen shoulder, while nearly 8 percent of women who hadn’t received HRT developed the condition, a rate roughly twice as high in the non-HRT group. The study did not establish causation, observational research cannot, but the signal is striking enough that it’s now driving prospective research.
A 2025 study in rats offers some clues to how estrogen may be protective, finding that estradiol helped prevent and even reverse fibrosis and scar tissue associated with frozen shoulder. Estradiol is the primary form of estrogen in the body during reproductive years, and watching it actively reverse scarring in joint tissue offers a biological explanation for why the observational data looked the way it did.
Biological studies examining the underlying causal processes now suggest the onset of frozen shoulder is associated with hormonal involvement, specifically estrogen. Given that hormone replacement therapy is widely prescribed to women experiencing menopause-related symptoms, investigators are exploring using HRT as an adjunct treatment for frozen shoulder. A UCSF trial is currently running a randomized controlled trial, the gold standard of evidence, testing whether HRT alongside standard care produces better outcomes than standard care alone. That trial is ongoing.
What This Means for Treatment Right Now
The honest answer is that the research is still catching up. Evidence strongly suggests a link between estrogen decline in menopause and the risk of frozen shoulder, but it remains unclear whether HRT is safe and effective as a direct treatment for the condition. The UCSF trial may change that picture, but results aren’t yet in.
In the meantime, the prognosis for patients with adhesive capsulitis is generally good with early and appropriate management. Physical therapy, anti-inflammatory medications, and corticosteroid injections can all help, with approximately 80% of patients regaining near-normal or normal shoulder function with proper treatment. Intra-articular corticosteroid injections outperformed physical therapy and non-steroidal anti-inflammatory drugs in reducing pain and improving function at 12 weeks. Catching frozen shoulder in its first stage, before the capsule fully contracts, gives treatment the best chance to work.
For women who are already on hormone therapy for other menopausal symptoms, the emerging evidence suggests this may offer some protection, though it’s not yet confirmed as a targeted treatment. For women who aren’t on HRT and aren’t candidates for it, the current treatment path remains the same: physical therapy, pain management during the freezing phase, and steroid injections when appropriate. Pushing through the pain in physical therapy, as counterintuitive as it feels, is important. The capsule won’t loosen if the shoulder stays still.
Menopause can also cause sleep difficulties, anxiety, and depression, which may further compound joint pain and stiffness. A shoulder that gets misattributed to stress or a rotator cuff problem can lose months of optimal treatment window, which is exactly why the hormonal context matters at the point of diagnosis, not after several rounds of the wrong treatment.
The Bigger Picture Nobody’s Talking About
Frozen shoulder sits inside a broader category that researchers writing in the Climacteric journal named the “musculoskeletal syndrome of menopause” in 2024. Joint pain, muscle loss, tendon changes, increased fracture risk, these are all downstream effects of estrogen decline, and frozen shoulder is one of the most debilitating among them. Women’s musculoskeletal health in midlife has been chronically understudied, and a shoulder problem in a 48-year-old woman rarely triggered a hormonal line of inquiry. That kept this connection invisible for so long.
The body of research is now shifting. The UCSF trial, the 2025 molecular study on estradiol and fibrosis, and the growing recognition of the musculoskeletal syndrome of menopause as a legitimate clinical category are all part of a surge of interest in what happens to women’s joints and connective tissue during and after perimenopause. For anyone sitting with an unexplained frozen shoulder, the hormonal context is information your doctor may not have volunteered, and the gap between the orthopedist managing your shoulder and the gynecologist managing your hormones is a real one that patients often have to bridge themselves.
What to Do With All of This
If you’re in your forties or early fifties and your shoulder has been getting progressively stiffer without a clear injury as the cause, pushing for an accurate diagnosis sooner rather than later is worth the effort. The earlier frozen shoulder is identified, the more treatment options are on the table. Corticosteroid injections in the freezing stage work better than at any other point. Physical therapy needs to begin while the capsule still has some give, starting it there is genuinely different from starting it at month ten.
Mention the perimenopause connection to your doctor, even if it feels like connecting two unrelated things. The research now supports that the connection is real, even if the underlying process isn’t fully mapped. Ask whether your hormonal status was considered as part of the picture. Most doctors managing shoulder pain aren’t gynecologists, and the conversation between those specialties is only beginning.
The recovery timeline for frozen shoulder is real and it is long. Some cases take up to 3 years from first symptom to full movement. What can change is how quickly you get to the right diagnosis, how early intervention starts, and whether the hormonal context gets factored into your care. For a condition that’s been routinely misattributed for decades, getting those things right makes the difference.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.